Product Images Venlafaxine Hydrochloride

This appears to be a table showing drug interactions and recommendations for use in patients with specific genetic profiles (CYP2D6 EM's and PM's). The table includes information on interacting drugs such as ethanol, Diazepam, Cimetdine, Ketoconazole, Indinavir, Metoprolol, and Lithium, as well as analyte venlafaxine. The table provides information on PK fold change and recommends avoiding concomitant use or using with caution in certain patient populations such as those with hypertension, elderly, or hepatic dysfunction. There is also a section related to changes relative to the reference value.*

This is a list of drugs and their potential interactions with each other. There are recommendations for changes in dosage or cautionary use for some drug combinations, while others are labeled as having no significant clinical significance. The list includes well-known drugs such as diazepam, caffeine, and lithium. There are also mentions of analyte PK fold changes and 90% C recommendation, which may be significant for medical professionals familiar with these terms.*

This appears to be a table or chart showing recommendations for dosage adjustments of the analyte venlafaxine in special populations with hepatic or renal impairment, CYP2D8 polymorphism, age, and gender. The table includes information on the fold change and 90% confidence interval for Cmax and AuC, but the formatting is difficult to interpret. It is possible that this table is part of a larger report or study on the pharmacokinetics of venlafaxine.*

EHCI is not a readable text. However, "venlafaxine hydrochloride" is a medication that belongs to the class of serotonin-norepinephrine reuptake inhibitors (SNRIs) commonly used to treat depression, anxiety disorders, and panic disorder.*

This is a description of Venlafaxine Hydrochloride Extended-Release Capsules, USP, distributed by Major Pharmaceuticals. The package contains 100 capsules with the NDC code 0804-7075-61. The medication guide must be dispensed by the pharmacist. There is another package with NDC 0904-7075-61 that is equivalent to the first. It is indicated for optional use only. The label includes dosage, pharmaceutical company information, and a lot number.*

This is a description of a medication for which the has picked up the following details: - The medicine is Venlafaxine Hydrochloride Extended-Release Capsules, USP - The capsules are available in a 75mg dosage form - The package comes in a Unit Dose which contains 100 capsules - The NDC code for the medicine is 0904-7077-61 - It is important for the pharmacist to dispense the medication along with a Medication Guide - There are some temperature and storage guidelines which need to be adhered to, though the has not been able to clearly dictate these instructions.*

This is a description of a medication named VENLAFAXINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. The medication comes in a bottle with 100 capsule units, each capsule contains a certain amount of the medication. A pharmacist should dispense the medicine with a medication guide. The text also provides additional information about the medication's ingredients, dosage and instructions on how to keep and distribute the medication.*